Dang, Q., Li, L., Xie, H., He, D., Chen, J., Song, W., . . . Chang, C. Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Wiley.
Chicago Style (17th ed.) CitationDang, Qiang, et al. Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals. Wiley.
MLA (9th ed.) CitationDang, Qiang, et al. Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals. Wiley.
Warning: These citations may not always be 100% accurate.